AR094132A1 - Vacunas peptidicas para la prevencion de la fiebre aftosa - Google Patents
Vacunas peptidicas para la prevencion de la fiebre aftosaInfo
- Publication number
- AR094132A1 AR094132A1 ARP130101063A ARP130101063A AR094132A1 AR 094132 A1 AR094132 A1 AR 094132A1 AR P130101063 A ARP130101063 A AR P130101063A AR P130101063 A ARP130101063 A AR P130101063A AR 094132 A1 AR094132 A1 AR 094132A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- attached
- prevention
- terminal end
- aftose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/641—Branched, dendritic or hypercomb peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
- A61K2039/645—Dendrimers; Multiple antigen peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Communicable Diseases (AREA)
Abstract
La solicitud se refiere a una construcción peptídica dendrimérica de fórmula (1) en la que: T es un epítopo T del VFA, unido al núcleo de lisina por su extremo N-terminal; B es un epítopo B del VFA, W es un grupo conectar, Z es Cys unida al grupo conector W a través de su átomo de azufre, o Lys unida al grupo conector W a través de su grupo e-amino; X no existe cuando B está unido al grupo a-carboxílico de Z por su extremo N-terminal, o es un grupo acilo cuando B está unido al grupo a-amino de Z por su extremo C-terminal. La solicitud también se refiere al uso de dichas construcciones como inmunógeno para la prevención de la fiebre aftosa en un animal.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12382135.7A EP2647390A1 (en) | 2012-04-02 | 2012-04-02 | Peptide vaccines for the prevention of foot-and-mouth disease |
Publications (1)
Publication Number | Publication Date |
---|---|
AR094132A1 true AR094132A1 (es) | 2015-07-15 |
Family
ID=48095811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP130101063A AR094132A1 (es) | 2012-04-02 | 2013-04-03 | Vacunas peptidicas para la prevencion de la fiebre aftosa |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2647390A1 (es) |
CN (1) | CN104363925B (es) |
AR (1) | AR094132A1 (es) |
WO (1) | WO2013149974A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3909970A1 (en) * | 2020-05-14 | 2021-11-17 | Consejo Superior De Investigaciones Científicas | Peptide vaccines for the prevention of foot-and-mouth disease |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US813998A (en) | 1903-10-31 | 1906-02-27 | Rail Joint Co | Insulated rail-joint. |
ES2319483B1 (es) | 2006-08-02 | 2010-02-10 | Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria | Construccion peptidica dendrimerica para la prevencion de la fiebre aftosa en animales. |
CN102168088B (zh) * | 2010-12-23 | 2012-12-26 | 中国农业科学院兰州兽医研究所 | T细胞免疫原基因ti及其在口蹄疫蛋白亚单位疫苗和灭活疫苗中的应用 |
-
2012
- 2012-04-02 EP EP12382135.7A patent/EP2647390A1/en not_active Withdrawn
-
2013
- 2013-04-01 CN CN201380028912.3A patent/CN104363925B/zh not_active Expired - Fee Related
- 2013-04-01 WO PCT/EP2013/056843 patent/WO2013149974A1/en active Application Filing
- 2013-04-03 AR ARP130101063A patent/AR094132A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2647390A1 (en) | 2013-10-09 |
CN104363925A (zh) | 2015-02-18 |
WO2013149974A1 (en) | 2013-10-10 |
CN104363925B (zh) | 2018-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2013000029A (es) | Anticuerpos peptidicos beta amiloide anti-n3pglu y usos de los mismos | |
CL2017000830A1 (es) | Formulación estable que comprende un azúcar no reductora, un anticuerpo anti-s4b7 y al menos un aminoácido libre; un método para preparar dicha formulación; uso de dicha formulación para tratar una enfermedad inflamatoria del intestino. | |
CY1116842T1 (el) | Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου | |
BR112015023105A8 (pt) | construto de imunógeno de peptídeo ab, seu uso, composição que o compreende, vacina de peptídeo para prevenção e imunoterapia de demência do tipo alzheimer e anticorpo. | |
PE20110023A1 (es) | Composiciones inmunogenicas de antigenos de staphylococcus aureus | |
CO6382140A2 (es) | Composiciones de vacuna que comprenden una proteina de enlace del factor h mutada | |
CY1117331T1 (el) | Αντισωματα προσδεσης στην εξωκυτταρικη περιοχη 4 του ανθρωπινου csf1r και η χρηση αυτων | |
ES2585328T3 (es) | Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis | |
BR112015013183A2 (pt) | proteínas de fusão para uso como aperfeiçoadores imunogênicos para indução de respostas de células t específicas para antígenos | |
CL2012003458A1 (es) | Vector que comprende un polipeptido antigénico de campylobacter; composicion farmacéutica que comprende dicho vector; uso del vector para mejorar respuesta inmune del sujeto al polipéptido antigénico. | |
UA118332C2 (uk) | Білок, що зв'язує антиген cd27l | |
CR20110091A (es) | Anticuerpos neutralizantes de citomegalovirus humano y uso de los mismos | |
UA109633C2 (uk) | Антитіло людини проти тканинного фактора | |
PE20142115A1 (es) | Composiciones de neisseria meningitidis y metodos de las mismas | |
CO6210756A2 (es) | La proteina linfopoyetina estromal timica canina y usos de la misma | |
PE20140986A1 (es) | Proteinas de fusion y vacunas de combinacion que comprenden proteina e y pilina a de haemophilus influenzae | |
AR060565A1 (es) | Vacuna para la gripe aviaria y metodos de uso | |
CY1120430T1 (el) | Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων | |
CL2008003197A1 (es) | Anticuerpo que se une especificamente a la region n-terminal del peptido alfa-beta8-x; hibridoma y proceso de preparacion del anticuerpo; metodo para detectar la carga amiloide in vitro en un mamifero; kit, composicion terapeutica y de vacuna que comprenden al anticuerpo; uso del anticuerpo para tratar la enfermedad de alzheimer. | |
UY33665A (es) | Derivado peptídico | |
PE20160878A1 (es) | Polipeptidos ciclicos para el tratamiento de la insuficiencia cardiaca | |
IT1397734B1 (it) | Uso di estratti naturali di tannini e non tannini atti a migliorare la fertilita' del suolo e determinare un effetto starter sulle colture, e fitocomplesso di tannini e di non tannini per tale uso. | |
EA201692279A1 (ru) | Способ уменьшения иммуногенности белка и пептида | |
AR092897A1 (es) | Composiciones inmunogenicas | |
MD20100029A (ro) | Herpesvirus recombinant al crapului de koi (KHV) sau Cyprinid herpesvirus 3 (CyHV-3) si vaccin pentru prevenirea bolii cauzate de KHV/CyHV-3 la Cyprinus carpio carpio sau Cyprinus carpio koi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |